DBV Technologies S.A.

Biotechnology company · Chatillon, Île-de-France, France · Nasdaq: DBVT

DBV Technologies S.A. is a biotechnology company headquartered in Chatillon, Île-de-France, France. Its shares trade on Nasdaq under the ticker DBVT. It has reported private securities offerings to the US SEC, most recently $307 million sold in a notice filed in 2025.

Profile compiled from public records. Is this your company? Request a correction or update

DBV Technologies at a glance

Typebiotechnology company

HeadquartersChatillon, Île-de-France, France

Stock listingNasdaq: DBVT

SEC industryBiological Products, (No Diagnostic Substances)

SEC CIK1613780

What does DBV Technologies do?

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $306.9 million sold (2025).

Frequently asked questions about DBV Technologies

Where is DBV Technologies headquartered?

DBV Technologies S.A. is headquartered in Chatillon, Île-de-France, France.

What does DBV Technologies do?

DBV Technologies S.A. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).

Is DBV Technologies a public company?

Yes. DBV Technologies S.A. trades on Nasdaq under the ticker DBVT.

Similar companies

Innate Pharma SAMarseille, Provence-Alpes-Côte d'Azur, France

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Sources

Location data: GeoNames (geonames.org), CC BY 4.0.

Last updated 2026-09-23.